Role of immune cells and immune-based therapies in pancreatitis and pancreatic ductal adenocarcinoma

Gastroenterology

Volumn 144, Issue 6, 2013, Pages 1230-1240

  Zheng, Lei ^a   Xue, Jing ^b   Jaffee, Elizabeth M ^a   Habtezion, Aida ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute Pancreatitis; Chronic Pancreatitis; Pancreatic Ductal Adenocarcinoma

Indexed keywords

BILIVERDIN; CANCER VACCINE; CARBON MONOXIDE; CERULETIDE; DENDRITIC CELL VACCINE; GEMCITABINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INFLIXIMAB; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; IPILIMUMAB; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; PERFORIN; RANTES; THROMBOCYTE ACTIVATING FACTOR; TOLL LIKE RECEPTOR 4; TRYPSINOGEN; TUMOR CELL VACCINE; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIGEN PRESENTATION; BACTERIAL COLONIZATION; BACTERIAL TRANSLOCATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ADHESION; CELL MEDIATED CYTOTOXICITY; CYTOKINE PRODUCTION; FIBROBLAST; HUMAN; HYPOXEMIA; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOPATHOGENESIS; IMMUNOREGULATION; IMMUNOTHERAPY; INFECTIOUS COMPLICATION; INFLAMMATION; INNATE IMMUNITY; INTESTINE FLORA; LEUKOCYTE MIGRATION; LIVER INJURY; MACROPHAGE ACTIVATION; MAST CELL; MEDIATOR RELEASE; MONOCYTE; MYELOID DERIVED SUPPRESSOR CELL; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS NECROSIS; PANCREATITIS; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; STROMAL FIBROBLAST; SUPPRESSOR CELL; T LYMPHOCYTE ACTIVATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT; UPREGULATION;

EID: 84876807399     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.12.042     Document Type: Article

References (102)

1. A.U. Shah, A. Sarwar, A.I. Orabi Protease activation during in vivo pancreatitis is dependent on calcineurin activation Ame J Physiol Gastrointest Liver Physiol 297 2009 G967 G973
2. A.K. Saluja, L. Bhagat, H.S. Lee Secretagogue-induced digestive enzyme activation and cell injury in rat pancreatic acini Am J Physiol 276 1999 G835 G842
3. J. Mayerle A novel role for leucocytes in determining the severity of acute pancreatitis Gut 58 2009 1440 1441
4. J.M. Braganza, S.H. Lee, R.F. McCloy Chronic pancreatitis Lancet 377 2011 1184 1197
5. H. Witt, M.V. Apte, V. Keim Chronic pancreatitis: challenges and advances in pathogenesis, genetics, diagnosis, and therapy Gastroenterology 132 2007 1557 1573
6. H. Pelli, J. Sand, P. Laippala Long-term follow-up after the first episode of acute alcoholic pancreatitis: time course and risk factors for recurrence Scand J Gastroenterol 35 2000 552 555
7. P.G. Lankisch, N. Breuer, A. Bruns Natural history of acute pancreatitis: a long-term population-based study Am J Gastroenterol 104 2009 2797 2805 quiz 2806
8. C. Nojgaard, U. Becker, P. Matzen Progression from acute to chronic pancreatitis: prognostic factors, mortality, and natural course Pancreas 40 2011 1195 1200
9. Y. Takeyama Long-term prognosis of acute pancreatitis in Japan Clin Gastroenterol Hepatol 7 Suppl 2009 S15 S57
10. D. Yadav, M. O'Connell, G.I. Papachristou Natural history following the first attack of acute pancreatitis Am J Gastroenterol 107 2012 1096 1103
11. R.W. Ammann, B. Muellhaupt, C. Meyenberger Alcoholic nonprogressive chronic pancreatitis: prospective long-term study of a large cohort with alcoholic acute pancreatitis (1976-1992) Pancreas 9 1994 365 373
12. C. Nojgaard Prognosis of acute and chronic pancreatitis - a 30-year follow-up of a Danish cohort Danish Med Bull 57 2010 B4228
13. J.B. Greer, D.C. Whitcomb Inflammation and pancreatic cancer: an evidence-based review Curr Opin Pharmacol 9 2009 411 418
14. A. Evans, E. Costello The role of inflammatory cells in fostering pancreatic cancer cell growth and invasion Front Physiol 3 2012 270
15. M.B. Wachsmann, L.M. Pop, E.S. Vitetta Pancreatic ductal adenocarcinoma: a review of immunologic aspects J Investig Med 60 2012 643 663
16. A. Neesse, P. Michl, K.K. Frese Stromal biology and therapy in pancreatic cancer Gut 60 2010 861 868
17. N. Jura, H. Archer, D. Bar-Sagi Chronic pancreatitis, pancreatic adenocarcinoma and the black box in-between Cell Res 15 2005 72 77
18. C.J. McKay, P. Glen, D.C. McMillan Chronic inflammation and pancreatic cancer Best Pract Res Clin Gastroenterol 22 2008 65 73
19. L.J. Vitone, W. Greenhalf, N.R. Howes Hereditary pancreatitis and secondary screening for early pancreatic cancer Rocz Akad Med Bialymst 50 2005 73 84
20. M. Goggins, S.E. Kern, J.A. Offerhaus Progress in cancer genetics: lessons from pancreatic cancer Ann Oncol 10 Suppl 1999 4 8 4
21. H. Rinderknecht Fatal pancreatitis, a consequence of excessive leukocyte stimulation? Int J Pancreatol 3 1988 105 112
22. V. Zaninovic, A.S. Gukovskaya, I. Gukovsky Cerulein upregulates ICAM-1 in pancreatic acinar cells, which mediates neutrophil adhesion to these cells Am J Physiol Gastrointest Liver Physiol 279 2000 G666 G676
23. A.S. Gukovskaya, E. Vaquero, V. Zaninovic Neutrophils and NADPH oxidase mediate intrapancreatic trypsin activation in murine experimental acute pancreatitis Gastroenterology 122 2002 974 984
24. A. Abdulla, D. Awla, H. Thorlacius Role of neutrophils in the activation of trypsinogen in severe acute pancreatitis J Leukoc Biol 90 2011 975 982
25. J.L. Frossard, A. Saluja, L. Bhagat The role of intercellular adhesion molecule 1 and neutrophils in acute pancreatitis and pancreatitis-associated lung injury Gastroenterology 116 1999 694 701
26. R. Makhija, A.N. Kingsnorth Cytokine storm in acute pancreatitis J Hepatobiliary Pancreat Surg 9 2002 401 410
27. C. McKay, C.W. Imrie, J.N. Baxter Mononuclear phagocyte activation and acute pancreatitis Scand J Gastroenterol Suppl 219 1996 32 36
28. M. Bhatia, R.D. Ramnath, L. Chevali Treatment with bindarit, a blocker of MCP-1 synthesis, protects mice against acute pancreatitis Am J Physiol Gastrointest Liver Physiol 288 2005 G1259 G1265
29. K. Saeki, T. Kanai, M. Nakano CCL2-induced migration and SOCS3-mediated activation of macrophages are involved in cerulein-induced pancreatitis in mice Gastroenterology 142 2012 1010 1020 e9
30. A. Demols, O. Le Moine, F. Desalle CD4(+)T cells play an important role in acute experimental pancreatitis in mice Gastroenterology 118 2000 582 590
31. R. Pezzilli, P. Billi, L. Gullo Behavior of serum soluble interleukin-2 receptor, soluble CD8 and soluble CD4 in the early phases of acute pancreatitis Digestion 55 1994 268 273
32. J. Xue, D.T. Nguyen, A. Habtezion Aryl hydrocarbon receptor regulates pancreatic IL-22 production and protects mice from acute pancreatitis Gastroenterology 143 2012 1670 1680
33. J.L. Frossard, M.L. Steer, C.M. Pastor Acute pancreatitis Lancet 371 2008 143 152
34. E. Polyzogopoulou, C. Bikas, D. Danikas Baseline hypoxemia as a prognostic marker for pulmonary complications and outcome in patients with acute pancreatitis Digest Dis Sci 49 2004 150 154
35. D. Closa, M. Bardaji, G. Hotter Hepatic involvement in pancreatitis-induced lung damage Am J Physiology 270 1996 G6 G13
36. R. Sharif, R. Dawra, K. Wasiluk Impact of toll-like receptor 4 on the severity of acute pancreatitis and pancreatitis-associated lung injury in mice Gut 58 2009 813 819
37. G. Chen, M.H. Shaw, Y.G. Kim NOD-like receptors: role in innate immunity and inflammatory disease Annu Rev Pathol 4 2009 365 398
38. S. Akira, K. Takeda Toll-like receptor signalling Nat Rev Immunol 4 2004 499 511
39. H.K. Gao, Z.G. Zhou, Y. Li Toll-like receptor 4 Asp299Gly polymorphism is associated with an increased risk of pancreatic necrotic infection in acute pancreatitis: a study in the Chinese population Pancreas 34 2007 295 298
40. Y. Takagi, A. Masamune, K. Kume Microsatellite polymorphism in intron 2 of human Toll-like receptor 2 gene is associated with susceptibility to acute pancreatitis in Japan Human Immunol 70 2009 200 204
41. H.G. Li, Z.G. Zhou, Y. Li Alterations of Toll-like receptor 4 expression on peripheral blood monocytes during the early stage of human acute pancreatitis Digest Dis Sci 52 2007 1973 1978
42. Y. Tsuji, T. Watanabe, M. Kudo Sensing of commensal organisms by the intracellular sensor NOD1 mediates experimental pancreatitis Immunity 37 2012 326 338
43. A. Ochi, A.H. Nguyen, A.S. Bedrosian MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells J Exp Med 209 2012 1671 1687
44. A.J. Rongione, A.M. Kusske, K. Kwan Interleukin 10 reduces the severity of acute pancreatitis in rats Gastroenterology 112 1997 960 967
45. G. Malleo, E. Mazzon, A.K. Siriwardena TNF-alpha as a therapeutic target in acute pancreatitis - lessons from experimental models Sci World J 7 2007 431 448
46. J.A. Dumot, D.L. Conwell, G. Zuccaro Jr A randomized, double blind study of interleukin 10 for the prevention of ERCP-induced pancreatitis Am J Gastroenterol 96 2001 2098 2102
47. J. Deviere, O. Le Moine, J.L. Van Laethem Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography Gastroenterology 120 2001 498 505
48. C.D. Johnson, A.N. Kingsnorth, C.W. Imrie Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis Gut 48 2001 62 69
49. J.K. Triantafillidis, P. Cheracakis, I.A. Hereti Acute idiopathic pancreatitis complicating active Crohn's disease: favorable response to infliximab treatment Am J Gastroenterol 95 2000 3334 3336
50. B. Gloor, T.A. Blinman, D.A. Rigberg Kupffer cell blockade reduces hepatic and systemic cytokine levels and lung injury in hemorrhagic pancreatitis in rats Pancreas 21 2000 414 420
51. S. Gea-Sorli, D. Closa In vitro, but not in vivo, reversibility of peritoneal macrophages activation during experimental acute pancreatitis BMC Immunol 10 2009 42
52. I. Nakamichi, A. Habtezion, B. Zhong Hemin-activated macrophages home to the pancreas and protect from acute pancreatitis via heme oxygenase-1 induction J Clin Invest 115 2005 3007 3014
53. A. Habtezion, R. Kwan, E. Akhtar Panhematin provides a therapeutic benefit in experimental pancreatitis Gut 60 2011 671 679
54. S. Gea-Sorli, D. Closa Role of macrophages in the progression of acute pancreatitis World J Gastrointest Pharmacol Ther 1 2010 107 111
55. K.H. Jung, S.U. Song, T. Yi Human bone marrow-derived clonal mesenchymal stem cells inhibit inflammation and reduce acute pancreatitis in rats Gastroenterology 140 2011 998 1008
56. M.B. Omary, A. Lugea, A.W. Lowe The pancreatic stellate cell: a star on the rise in pancreatic diseases J Clin Invest 117 2007 50 59
57. M.V. Apte, R.C. Pirola, J.S. Wilson Molecular mechanisms of alcoholic pancreatitis Digest Dis 23 2005 232 240
58. A. Schmid-Kotsas, H.J. Gross, A. Menke Lipopolysaccharide-activated macrophages stimulate the synthesis of collagen type I and C-fibronectin in cultured pancreatic stellate cells Am J Pathol 155 1999 1749 1758
59. M. Treiber, P. Neuhofer, E. Anetsberger Myeloid, but not pancreatic, RelA/p65 is required for fibrosis in a mouse model of chronic pancreatitis Gastroenterology 141 2011 1473 1485 1485 e1-e7
60. R.E. Hunger, C. Mueller, K. Z'Graggen Cytotoxic cells are activated in cellular infiltrates of alcoholic chronic pancreatitis Gastroenterology 112 1997 1656 1663
61. M. Grundsten, G.Z. Liu, J. Permert Increased central memory T cells in patients with chronic pancreatitis Pancreatology 5 2005 177 182
62. H. Schmitz-Winnenthal, D.H. Pietsch, S. Schimmack Chronic pancreatitis is associated with disease-specific regulatory T-cell responses Gastroenterology 138 2010 1178 1188
63. Y.C. Chan, P.S. Leung Acute pancreatitis: animal models and recent advances in basic research Pancreas 34 2007 1 14
64. A.A. Aghdassi, J. Mayerle, S. Christochowitz Animal models for investigating chronic pancreatitis Fibrogenesis Tissue Repair 4 2011 26
65. F. Marrache, S.P. Tu, G. Bhagat Overexpression of interleukin-1beta in the murine pancreas results in chronic pancreatitis Gastroenterology 135 2008 1277 1287
66. P.A. Perez-Mancera, C. Guerra, M. Barbacid What we have learned about pancreatic cancer from mouse models Gastroenterology 142 2012 1079 1092
67. C.E. Lewis, J.W. Pollard Distinct role of macrophages in different tumor microenvironments Cancer Res 66 2006 605 612
68. A. Mantovani, W.J. Ming, C. Balotta Origin and regulation of tumor-associated macrophages: the role of tumor-derived chemotactic factor Biochim Biophys Acta 865 1986 59 67
69. A. Sica, P. Larghi, A. Mancino Macrophage polarization in tumour progression Semin Cancer Biol 18 2008 349 355
70. H. Kurahara, H. Shinchi, Y. Mataki Significance of M2-polarized tumor-associated macrophage in pancreatic cancer J Surg Res 167 2011 e211 e219
71. B. Baran, I. Bechyne, M. Siedlar Blood monocytes stimulate migration of human pancreatic carcinoma cells in vitro: the role of tumour necrosis factor-alpha Eur J Cell Biol 88 2009 743 752
72. D.I. Gabrilovich, S. Nagaraj Myeloid-derived suppressor cells as regulators of the immune system Nat Rev Immunol 9 2009 162 174
73. S. Ostrand-Rosenberg, P. Sinha Myeloid-derived suppressor cells: linking inflammation and cancer J Immunol 182 2009 4499 4506
74. C.E. Clark, S.R. Hingorani, R. Mick Dynamics of the immune reaction to pancreatic cancer from inception to invasion Cancer Res 67 2007 9518 9527
75. L.J. Bayne, G.L. Beatty, N. Jhala Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer Cancer Cell 21 2012 822 835
76. Y. Pylayeva-Gupta, K.E. Lee, C.H. Hajdu Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia Cancer Cell 21 2012 836 847
77. M.D. Reid, O. Basturk, D. Thirabanjasak Tumor-infiltrating neutrophils in pancreatic neoplasia Mod Pathol 24 2011 1612 1619
78. Z.G. Fridlender, S.M. Albelda Tumor-associated neutrophils: friend or foe? Carcinogenesis 33 2012 949 955
79. A.M. Gilfillan, M.A. Beaven Regulation of mast cell responses in health and disease Crit Rev Immunol 31 2011 475 529
80. D.Z. Chang, Y. Ma, B. Ji Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma Clin Cancer Res 17 2011 7015 7023
81. S.W. Cai, S.Z. Yang, J. Gao Prognostic significance of mast cell count following curative resection for pancreatic ductal adenocarcinoma Surgery 149 2011 576 584
82. I. Esposito, M. Menicagli, N. Funel Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma J Clin Pathol 57 2004 630 636
83. N. Hiraoka, K. Onozato, T. Kosuge Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions Clin Cancer Res 12 2006 5423 5434
84. G. Bellone, A. Turletti, E. Artusio Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients Am J Pathol 155 1999 537 547
85. E. Tassi, F. Gavazzi, L. Albarello Carcinoembryonic antigen-specific but not antiviral CD4+ T cell immunity is impaired in pancreatic carcinoma patients J Immunol 181 2008 6595 6603
86. L. De Monte, M. Reni, E. Tassi Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer J Exp Med 208 2011 469 478
87. A. Fukunaga, M. Miyamoto, Y. Cho CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma Pancreas 28 2004 e26 e31
88. L. Degrate, C. Nobili, C. Franciosi Interleukin-2 immunotherapy action on innate immunity cells in peripheral blood and tumoral tissue of pancreatic adenocarcinoma patients Langenbecks Arch Surg 394 2009 115 121
89. C. Feig, A. Gopinathan, A. Neesse The pancreas cancer microenvironment Clin Cancer Res 18 2012 4266 4276
90. B. Farrow, D. Albo, D.H. Berger The role of the tumor microenvironment in the progression of pancreatic cancer J Surg Res 149 2008 319 328
91. M. Kraman, P.J. Bambrough, J.N. Arnold Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha Science 330 2010 827 830
92. S.R. Hingorani, E.F. Petricoin, A. Maitra Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse Cancer Cell 4 2003 437 450
93. C. Guerra, A.J. Schuhmacher, M. Canamero Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice Cancer Cell 11 2007 291 302
94. C. Guerra, M. Collado, C. Navas Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence Cancer Cell 19 2011 728 739
95. J. Emmrich, I. Weber, M. Nausch Immunohistochemical characterization of the pancreatic cellular infiltrate in normal pancreas, chronic pancreatitis and pancreatic carcinoma Digestion 59 1998 192 198
96. E.M. Jaffee, R.H. Hruban, B. Biedrzycki Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation J Clin Oncol 19 2001 145 156
97. E. Lutz, C.J. Yeo, K.D. Lillemoe A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma A phase II trial of safety, efficacy, and immune activation Ann Surg 253 2011 328 335
98. A.J. Lepisto, A.J. Moser, H. Zeh A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors Cancer Ther 6 2008 955 964
99. R.E. Royal, C. Levy, K. Turner Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma J Immunother 33 2010 828 833
100. J.R. Brahmer, S.S. Tykodi, L.Q. Chow Safety and activity of anti-PD-L1 antibody in patients with advanced cancer N Engl J Med 366 2012 2455 2465
101. D.T. Le, E. Lutz, L. Huang 2012 GI ASCO abstract J Clin Oncol 30 Suppl 4 2012 abstr 211
102. G.L. Beatty, E.G. Chiorean, M.P. Fishman CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans Science 331 2011 1612 1616